A recent Nature publication further showed that a bimodal molecule combining GLP-1 receptor agonism with NMDA receptor antagonism could reverse obesity and hyperglycaemia in rodent models, with targeted effects on hypothalamic and brainstem neuroplasticity (Petersen et al., 2024, DOI)
GIP receptor activation in the hypothalamus reduces food intake through mechanisms that are distinct from and complementary to GLP-1 pathways
If you are experiencing a severe, persistent headache that comes with vomiting, blurry vision, or other symptoms that are concerning, seek your doctors help right away
You may not be a good fit for a GLP-1 prescription if: You have a personal or family history of medullary thyroid carcinoma (MTC)
Then, weekly for a few more weeks
The models and images used in this website are not images of our own patients.